The global oral contraceptive pills market for the historical period 2017–2018 and forecast period 2019–2027, high incidence of unintended pregnancies, awareness programs by governments and NGOs, increase in maternal age and late pregnancies are projected to drive the global oral contraceptive pills market during the forecast period. According to the report, the global oral contraceptive pills market was valued at US$ 1 Bn in 2018 and is anticipated to expand at a CAGR of 6% from 2019 to 2027.
Unintended Pregnancies Still Leading Driving Factor for Market Growth
Contraceptive pill or birth control pill is a daily pill that contains hormones to change the way the body works and prevents pregnancy. Two main types of oral contraceptive pills are available in the market: combination pill containing two hormones (estrogen and progestin) and progestin-only pill. Contraceptive pill or birth control pill is a daily pill that contains hormones to change the way the body works and prevent pregnancy. Two main types of oral contraceptive pills are available in the market: combination pill containing two hormones (estrogen and progestin) and progestin-only pill. High incidence of unintended pregnancies among women aged between 15 and 44 drives the demand for contraceptives. Large percentage of these unintended pregnancies result in abortions, which entail preventable healthcare expenditure. In an attempt to curb this redundant healthcare expenditure, governments of various countries, including developed and developing nations such as the U.S., Sweden, Norway, and India, encourage women to opt for more effective modern contraceptive methods.
Get a sample of the report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8323
Governments of various countries and NGOs such as Population Services International (PSI), Marie Stopes International, and Futures Group, along with prominent market players organize family planning programs and contraception awareness programs to expand the knowledge about contraceptives and their advantages in preventing pregnancy. For instance, Marie Stopes International entered into strategic agreements with contraceptive manufacturers, such as Bayer HealthCare, to cater to the unmet contraception (pill and implant) needs of women in the emerging and underdeveloped (Africa) economies by reducing prices.
Social Taboos to Hamper Market Growth
Contraceptive drugs involve several health risks and side effects, discouraging their use in women. Hence, women opt for natural contraceptive and permanent contraceptive methods such as sterilization, vasectomy, tubal ligation, and withdrawal. Contraceptive pills carry serious long-term and life-threatening side effects such as increased risk of breast cancer, blood clots, and stroke. This discourages the consumers from using them. Other side effects include high blood pressure, nausea, stroke, dizziness, and mood swings. Various ethical and social issues regarding certain contraceptive methods, especially contraceptive pills, lead to restriction on their usage in some countries. These factors can continue restricting the growth of oral contraceptive pills market by a certain degree in coming years. Players and manufacturers in oral contraceptive pills market are constantly engaged in clinical trials and studies to develop newer, more potent, and safe to use drugs and medications. Increased investments in research and development activities by various government and non-government organizations is also expected to positively affect global oral contraceptive pills market in coming years.
Request for Analysis of COVID-19 Impact on Oral Contraceptive Pills Market @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=8323
In terms of region, the global oral contraceptive pills market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global oral contraceptive pills market in 2018, followed by Europe. North America accounted for major share of the global oral contraceptive pills market in 2018, owing to increase in abortion rate and unintended pregnancies, new product launch, and presence of major players.
The global oral contraceptive pills market is fragmented in terms of number of players. Key players in the global market include Allergan plc, Bayer AG, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Piramal Enterprises, and Syzygy Healthcare LLC, among others.
Global Oral Contraceptive Pills Market: Segmentation
Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=8323
Oral Contraceptive Pills Market, by Type
- Progestin Only
Oral Contraceptive Pills Market, by Category
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453
Email: [email protected]